Sunstone Therapies presents data at ASCO showing positive long-term follow-up results from psilocybin therapy in cancer patients ...
Sunstone Therapies presents data at ASCO showing positive long-term follow-up results from psilocybin therapy in cancer patients with major depressive disorder (MDD) 18-month follow-up of patients in phase 2 study shows continued robust clinical response …